A commercial agreement has been reached between 3D Systems, the industry leader in additive manufacturing technologies, and Theradaptive, a biopharmaceutical business pioneering tailored regenerative treatments, designating 3D Systems as Theradaptive's sole 3D printing partner.
Biocomposites, has entered into a multiyear agreement with Zimmer Biomet to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market. Biocomposites is an international medical device company that engineers, manufactures, and markets world-leading products for regenerating bone and managing infection in bone and soft tissue.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5530
Published Date: Jan 12, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The major factors driving the growth of the market are rise in geriatric population, surge in prevalence of obesity, and rising prevalence of tendinitis in sports people.
The market size of soft tissue repair is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024 â€“ 2036.
The major players in the market are 3D Systems, Biocomposites, Medtronic plc, Stryker, and others.
The hospitals & clinics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North America market is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.